Salmeterol (42 mu g BID) improves clinical outcomes adolescents and adults with nocturnal asthma.

被引：0

作者：

DuBuske, L

Cox, F

Bowers, B

Emmett, A

Kalberg, C

Petrocella, V

Rickard, K

机构：

[1] ALLERGY & ARTHRIT FAMILY TREATMENT CTR,GARDNER,MA

[2] GLAXO WELLCOME INC,RES TRIANGLE PK,NC 27709

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1997年 / 99卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1327 / 1327

页数：1

共 15 条

[1] Salmeterol (42 mu g BID) improves clinical outcomes in adolescents and adults with moderate to severe asthma.
Murray, J
Bowers, B
Cox, F
Emmett, A
Kalberg, C
Petrocella, V
Rickard, K
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1329 - 1329
[2] Superior improvement in quality of life for patients with nocturnal asthma receiving Salmeterol xinafoate 42 mu g BID (SLG) versus placebo (PL).
Cox, F
Bowers, B
Friedman, B
Petrocella, V
Emmett, A
Rickard, K
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1307 - 1307
[3] Nocturnal asthma - Effect of salmeterol on quality of life and clinical outcomes
Lockey, RF
DuBuske, LM
Friedman, B
Petrocella, V
Cox, F
Rickard, K
CHEST, 1999, 115 (03) : 666 - 673
[4] The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review
Roche, N.
Aggarwal, B.
Mittal, L.
Martin, A.
Chrystyn, H.
Boucot, I.
RESPIRATORY MEDICINE, 2022, 202
[5] Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/250μg vs fluticasone propionate 250μg in adults and adolescents with asthma IV:: Results
Palmqvist, M
Price, MJ
Sondhi, S
PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 23 - 28
[6] Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/100μg vs fluticasone propionate 100μg in adults and adolescents with asthma III:: Results
Johansson, G
Price, MJ
Sondhi, S
PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 15 - 21
[7] Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/100μg vs Fluticasone Propionate 100μg in Adults and Adolescents with Asthma III: Results
Gunnar Johansson
Martin J. Price
Seema Sondhi
PharmacoEconomics, 1999, 16 : 15 - 21
[8] Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/250μg vs Fluticasone Propionate 250μg in Adults and Adolescents with Asthma IV: Results
Mona Palmqvist
Martin J. Price
Seema Sondhi
PharmacoEconomics, 1999, 16 : 23 - 28
[9] Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 μg twice daily and budesonide 800 μg twice daily in the treatment of adults and adolescents with asthma
Lundbäck, B
Jenkins, C
Price, MJ
Thwaites, RMA
RESPIRATORY MEDICINE, 2000, 94 (07) : 724 - 732
[10] Effect Of Tiotropium Respimat® 2.5 μg Add-On To Ics Or Ics plus controller Medications On Clinical Outcomes In Adults And Adolescents With Asthma Across Severities
Meltzer, E.
Shaikh, A.
Engel, M.
Sigmund, R.
Berger, W.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195

← 1 2 →